RFK Jr., flu shots, dementia, Elf Bar: Morning Rounds

The White House’s Battle Against Vaccine Skepticism

Health secretary Robert F. Kennedy Jr. has spent the past year transforming the federal government’s approach to vaccines. However, White House officials are now trying to distance themselves from Kennedy and his Make America Healthy Again movement due to concerns about the topic’s unpopularity in an election year.

Despite bipartisan support for the childhood vaccine schedule, some Trump administration officials are eager to move on from the vaccine issue. They point to a recent poll that showed strong backing for vaccines in key congressional districts. “We’re just kind of done with the vaccine issue,” said one White House official.

On the other hand, MAHA supporters are not backing down. A clash is brewing between Trump and Kennedy’s movements, and STAT’s Daniel Payne and Chelsea Cirruzzo provide an in-depth look at the situation.

The FDA’s Potential Authorization of New Vape Flavors

The Food and Drug Administration has released draft guidance suggesting that additional vape flavors may soon be authorized for sale. This news has sparked concern among public health experts, who fear that new flavors like coffee, mint, and cinnamon could attract children and reverse the progress made in reducing youth e-cigarette usage.

While flavored products can help adults transition away from traditional cigarettes, experts are cautious about the impact of introducing new vape flavors. The FDA’s guidance avoids sweet flavorings that were previously linked to youth vaping in the late 2010s. STAT’s Sarah Todd delves into the debate over the benefits of more vaping flavors and the evidence required for manufacturers to bring their products to market.

Exciting Discovery in Cancer Immunotherapy

A recent study published in Science unveils a promising discovery in cancer immunotherapy. Scientists have identified an unusual protein, Src, on the surface of cancer cells, which could serve as a potential target for immunotherapy in solid tumors.

Most immunotherapies rely on targeting specific markers on cancer cells to trigger the immune system’s response. However, this approach is less effective for solid tumors, as many cell surface proteins are shared with healthy cells. Src’s presence on cancer cells could offer a new avenue for developing medications.

While this finding isn’t a cure-all, it represents a significant step forward in cancer treatment. STAT’s Angus Chen provides a comprehensive overview of the study, including researchers’ insights into why cancer cells exhibit Src on their outer membrane.

Next Year’s Flu Shots and FDA Recommendations

An FDA advisory committee recently recommended that flu vaccine manufacturers align next winter’s flu shots with the strains recommended by the World Health Organization. This decision follows concerns about the late emergence of a new strain of H3N2 and its potential impact on the effectiveness of the current flu shot.

Despite calls for flu vaccine manufacturers to conduct effectiveness trials before licensing updated shots, experts acknowledge the logistical challenges of such a demand. The committee also heard a report on the effectiveness of this year’s flu shots, with the CDC noting moderate protection against hospitalization for vaccinated individuals.

As the market for flu shots shrinks, manufacturers face new challenges in meeting demand. Helen Branswell provides insights into the committee’s discussions and the evolving landscape of flu vaccine production.

Public Perception of Drug Price Policies

A recent poll by KFF reveals that Americans are more likely to credit the Trump administration over the Biden administration for efforts to lower drug prices. Trump’s TrumpRx initiative, which aims to reduce prescription drug costs, has garnered significant support among respondents.

While both administrations have prioritized lowering drug prices, Trump’s policies have resonated more with the public. The poll highlights the differing perceptions of Republicans and Democrats regarding the effectiveness of each administration’s approach to drug pricing.

STAT’s John Wilkerson explores the poll findings in detail, shedding light on the public’s awareness of drug price policies and the factors influencing their views.

The Role of Surrealism in Dementia Care

In a thought-provoking piece, Jason Karlawish discusses the potential of surrealism in dementia care. People living with dementia, especially in advanced stages, often struggle to distinguish between reality and fantasy. Surrealism challenges this dichotomy by disrupting traditional notions of reality through artistic techniques like collage and painting.

By embracing surrealism, caregivers can navigate the complexities of dementia and better understand their patients’ experiences. Karlawish explores how concepts from surrealist art, such as exquisite corpses and André Breton’s work, can provide valuable insights for dementia care.

In conclusion, these diverse topics offer a glimpse into the complexities of healthcare, public health, and medical research. From vaccine skepticism to cancer immunotherapy and flu vaccine recommendations, each issue highlights the ongoing challenges and innovations in the field of medicine. As policymakers, healthcare providers, and researchers continue to address these issues, it is crucial to stay informed and engaged with the latest developments in healthcare.